Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03147118 · ClinicalTrials.gov registry record

Evaluating Palpation Guided Injections in Trapeziometacarpal Arthritis

A clinical trial, sponsored by Prisma Health-Upstate.

Completed
Registry status
37
Enrollment target

NCT03147118 is a clinical trial that has completed, run by Prisma Health-Upstate. The registered enrollment target is 37 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03147118 has completed, sponsored by Prisma Health-Upstate.

COMPLETED
Registry status
37 participants
Enrollment target

Study Summary

The objective of this study is to evaluate the accuracy of trapeziometacarpal injections using palpation alone. The importance of this study is one of education, cost containment, and decreased risk to the patient. If it can be shown that the accuracy of trapeziometacarpal injections using palpation alone is similar to the reported accuracy of ultrasound and fluoroscopy, then these guided techniques may not be needed.

Interventions

  • DIAGNOSTIC_TEST Arthrogram

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2017-05-01
Est. Completion 2017-09-15

Sponsor

Prisma Health-Upstate

67 total trials

What the Registry Record Tells You About NCT03147118

The ClinicalTrials.gov registry entry for NCT03147118 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prisma Health-Upstate, which has 67 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Arthrogram is the first listed.

NCT03147118 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03147118 about?

NCT03147118 is a clinical study titled "Evaluating Palpation Guided Injections in Trapeziometacarpal Arthritis". The objective of this study is to evaluate the accuracy of trapeziometacarpal injections using palpation alone. The importance of this study is one of education, cost containment, and decreased risk to the patient. If it can be shown that the accuracy of trapeziometacarpal injections using palpation...

What is the current status of trial NCT03147118?

This trial is currently completed. The enrollment target is 37 participants. The study started on 2017-05-01. Estimated completion is 2017-09-15.

What interventions are being tested in trial NCT03147118?

The interventions under investigation include: Arthrogram (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03147118?

This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.